Reproductive endocrinology

Effects of Isoflavone Interventions on Bone Metabolism in Perimenopausal and Postmenopausal Women: An Umbrella Review of Meta-Analyses of Randomized Controlled Trials

Endocr PractPublished Umbrella review of meta-analyses of randomised controlled trials

Authors' conclusion

Our findings indicate that isoflavone interventions have the potential to improve BMD at different bone sites, including the lumbar spine, femoral neck, and total hip in perimenopausal and postmenopausal women. Isoflavone may be considered a complementary option in the bone loss of perimenopausal and postmenopausal women.

Study context

Population
Perimenopausal and postmenopausal women10 meta-analyses of RCTs
Comparison
Isoflavone interventions vs control
Outcome
BMD
Methodological detailsrandom-effects model, PRISMA guidelines, Databases searched from inception to August 24, 2023: PubMed, Embase, Cochrane, Web of Science
  • Random-effects model
  • PRISMA guidelines
  • Databases searched from inception to August 24, 2023: PubMed, Embase, Cochrane, Web of Science

Pooled result

As reported in the abstract

Lumbar spine BMD increased with isoflavone, MD

11.50 mg/cm²

95% CI 6.46 to 16.55

Femoral neck BMD increased with isoflavone, MD

2.03%

95% CI 0.57 to 3.50

Top hip BMD increased with isoflavone, MD

0.31%

95% CI 0.03 to 0.59

Original publication

Effects of Isoflavone Interventions on Bone Metabolism in Perimenopausal and Postmenopausal Women: An Umbrella Review of Meta-Analyses of Randomized Controlled Trials. Endocr Pract. Published 28 August 2024. doi:10.1016/j.eprac.2024.08.009

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.